Imported baby formula would be subject to tariffs again in the new year after the expiration of exemptions implemented amid a nationwide shortage, the Wall Street Journal reported on Wednesday.
https://www.pharmalive.com/wp-content/uploads/2022/12/ReutersSimilac12-28-2022.jpg8001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-12-28 10:17:022022-12-28 11:37:18Baby formula imports to face tariffs again in 2023 – WSJ
